<p>The invention provides compounds of formula (I): wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of replication of the hepatitis C virus. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat hepatitis C viral infections, and processes and intermediates useful for preparing such compounds.</p>
申请公布号
EP2635571(A1)
申请公布日期
2013.09.11
申请号
EP20110784875
申请日期
2011.11.03
申请人
THERAVANCE, INC.
发明人
MCKINNELL, ROBERT MURRAY;LONG, DANIEL D.;VAN ORDEN, LORI JEAN;JIANG, LAN;LOO, MANDY;SAITO, DAISUKE ROLAND;ZIPFEL, SHEILA;STANGELAND, ERIC L.;LEPACK, KASSANDRA;OGAWA, GAVIN;HUANG, XIAOJUN;ZHANG, WEIJIANG